Cargando…
Toward interchangeable biologics
A biosimilar is designed to match the reference product – to be as close to the reference as the reference is to itself considering batch‐to‐batch variability and manufacturing changes over its lifetime.(1) Interchangeability will require additional data, however, the interchangeable biologic itself...
Autores principales: | McCamish, M, Pakulski, J, Sattler, C, Woollett, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706804/ https://www.ncbi.nlm.nih.gov/pubmed/25670498 http://dx.doi.org/10.1002/cpt.39 |
Ejemplares similares
-
The Continuum of Comparability Extends to Biosimilarity: How Much Is Enough and What Clinical Data Are Necessary?
por: McCamish, M, et al.
Publicado: (2013) -
Worldwide experience with biosimilar development
por: McCamish, Mark, et al.
Publicado: (2011) -
Interchangeability for Biologics is a Legal Distinction in the USA, Not a Clinical One
por: Park, Joseph P., et al.
Publicado: (2022) -
Recombinant Human Leptin Treatment Does Not Improve Insulin Action in Obese Subjects With Type 2 Diabetes
por: Mittendorfer, Bettina, et al.
Publicado: (2011) -
Interchange /
por: C. Richards, Jack
Publicado: (2013)